If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
Heck yea Dude! How about getting some good insider info and then PM it to me...jejeje
Seriously though, see what kind of info you can get him to give up. Explain to him that you and a few others hoping to profit from his company.
Maybe King could think of some specific questions. King? Oh King?
We didn't discuss any insider information, but I did find out about the small Canadian biotech working with ELN on their next Alzheimer's vaccine candidate. She recommended taking a look at Transition Therapeutics (TTH.TO) while it's still under $1. The clinical data for this drug looks good enough for ELN to commit $200M to its development, and if it works, the upside for both ELN, and especially TTH will be HUGE.
I took a quick look at the TTH, and so far like very much what I'm seeing. Not only do they have the Alzheimer's drug, but several other diabetes, MS, and HCV drugs in development. I'll look more into these guys, but please read their latest report yourselves, and let me know what you think of TTH:
I like the set up into support. I might risk .83 cents on it. I'll also look for entry off a 60 min chart. Nice eye Spike.
Thnx, and good luck, Runner. I'm broader market very bearish intraday and see high potential for some fast and volatile correctives now. Looks like Dow has put in a big 5th with subwaves 5th now. Earnings disappointments tonight will likely fuel the drop.
I'd feel a whole lot better about this ELN long if it was supported by my market bias, but ya can't have everything
I will note that I count a long-term fuzzy C at 14.33...so failure of that support will be very bearish for ELN. Here's a fuzzy count from earlier in the year that shows the pink fuzzy C at 12.00ish, which is also important support naturally. I'm about to redo the count now to highlight that $14.33 zone.
I also like the TA setup here. The short term catalyst for breakout should be the earnings report before the bell on 10/25 with a great earnings projection due to TYSABRI sales in Canada?
Comment